Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Homology Medicines, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues21.45,695.0
            Revenue growth-99.6% 
Cost of goods sold29.710,000.0
Gross profit-8.3-4,305.0
            Gross margin-38.7%-75.6%
General and administrative8.34,305.0
EBIT-29.7-10,000.0
            EBIT margin-138.7%-175.6%
Pre-tax income0.00.0
Income taxes0.00.0
Net income0.00.0
            Net margin0.0%0.0%
 
Diluted EPS$0.00$0.00
Shares outstanding (diluted)2,479.41,900.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy